Correlation Between NewAmsterdam Pharma and Dyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Dyne Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Dyne Therapeutics.
Diversification Opportunities for NewAmsterdam Pharma and Dyne Therapeutics
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NewAmsterdam and Dyne is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Dyne Therapeutics go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Dyne Therapeutics
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Dyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 1.36 times less risky than Dyne Therapeutics. The stock trades about -0.37 of its potential returns per unit of risk. The Dyne Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 1,367 in Dyne Therapeutics on November 28, 2024 and sell it today you would earn a total of 36.00 from holding Dyne Therapeutics or generate 2.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Dyne Therapeutics
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Dyne Therapeutics |
NewAmsterdam Pharma and Dyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Dyne Therapeutics
The main advantage of trading using opposite NewAmsterdam Pharma and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |